Pharmacophore Refinement
Pharmacophore Refinement is a systematic optimization process in pharmacophore modeling whereby an initial pharmacophore hypothesis is iteratively modified—by adjusting, adding, or removing features and constraints in light of structure–activity, structural, and validation data—to improve its consistency with known ligands and its predictive performance in virtual screening and drug design.
325
Publications
13.3K
Citations
1.6K
Authors
483
Institutions
Publications per year
2017–2026
66
Parents
325
1–5 of 325
1.6K
7
h-index
7
h-index
5
h-index
5
h-index
4
h-index
1–5 of 1.6K
483

Sichuan University
Chengdu, China
10 h-index
70 publications
2.3K citations

China Pharmaceutical University
Nanjing, China
7 h-index
38 publications
1.1K citations

Gyeongsang National University
Jinju-si, South Korea
6 h-index
28 publications
719 citations

Chinese Academy of Sciences
Beijing, China
6 h-index
19 publications
1.1K citations

Centre National de la Recherche Scientifique
Paris, France
5 h-index
23 publications
1K citations
University of Jordan
Amman, Jordan
5 h-index
9 publications
382 citations
University of Sheffield
Sheffield, United Kingdom
5 h-index
13 publications
1.6K citations
Pfizer (United States)
New York, United States
5 h-index
44 publications
1.8K citations
1–8 of 483
34 publications · 2.4K citations
29
h-index
42 publications · 1.3K citations
23
h-index
24 publications · 1.8K citations
19
h-index
20 publications · 674 citations
15
h-index
JCIM · 13 publications · 452 citations
13
h-index
1–5